Warby Parker Inc. (WRBY) Operating Margin
- Operating margin · 12 months: Value 0.17%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 0.17% | Operating income / revenue. Period ending 2026-06-30. $1.55M ÷ $911.61M × 100 ≈ 0.17% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.55M USD | Operating Income (Loss) |
| Revenue | 911.61M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 413.12M USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 496.94M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.55M | $911.61M | $413.12M | (m) | $496.94M | 0.17% |
| 2026-03-31 | $-6.14M | $890.57M | $414.93M | (m) | $481.78M | -0.69% |
| 2025-12-31 | $-5.34M | $871.90M | $401.33M | (m) | $475.92M | -0.61% |
| 2025-09-30 | $-7.90M | $850.58M | $387.92M | (m) | $470.56M | -0.93% |
| 2025-06-30 | $-18.08M | $821.35M | $373.76M | (m) | $465.67M | -2.20% |
| 2025-03-31 | $-22.51M | $795.09M | $355.74M | (m) | $461.87M | -2.83% |
| 2024-12-31 | $-30.11M | $771.32M | $344.48M | (m) | $456.95M | -3.90% |
| 2024-09-30 | $-42.27M | $742.53M | $331.75M | (m) | $453.04M | -5.69% |
| 2024-06-30 | $-55.42M | $719.93M | $321.29M | (m) | $454.06M | -7.70% |
| 2024-03-31 | $-64.69M | $697.80M | $313.91M | (m) | $448.58M | -9.27% |
| 2023-12-31 | $-72.00M | $669.76M | $304.54M | (m) | $437.22M | -10.75% |
| 2023-09-30 | $-72.14M | $654.40M | $295.59M | (m) | $430.95M | -11.02% |
| 2023-06-30 | $-76.04M | $633.33M | $282.84M | (m) | $426.54M | -12.01% |
| 2023-03-31 | $-89.89M | $616.86M | $270.65M | (m) | $436.10M | -14.57% |
| 2022-12-31 | $-111.20M | $598.11M | $257.05M | (m) | $452.26M | -18.59% |
| 2022-09-30 | $-135.39M | $584.51M | $247.85M | (m) | $472.05M | -23.16% |
| 2022-06-30 | $-203.69M | $573.11M | $241.20M | (m) | $535.60M | -35.54% |
| 2022-03-31 | $-180.42M | $555.04M | $231.43M | (m) | $504.04M | -32.51% |
| 2021-12-31 | $-143.66M | $540.80M | $223.05M | (m) | $461.41M | -26.56% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-55.63M | $393.72M | $161.78M | (m) | $287.57M | -14.13% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-1.66M | $370.46M | $147.35M | (m) | $224.77M | -0.45% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |